Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the complete record of transactions filed by Christianson Mark, Directeur du Développement Commercial. Director active across 1 company, notably NEUROONE MEDICAL TECHNOLOGIES Corp. Aggregated, 51 filings have been published. Breakdown: 0 buy · 15 sells. Total volume traded: €224k. Activity tracked since 23 June 2021. The latest transaction was filed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Christianson Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
90 títulos@ 0,9299 US$0.0% de su flujoCommon StockSEC:0001709738-24-000007:0
25 de 51 declaraciones
About Christianson Mark
Christianson Mark is Business Development Director and is associated with filings for NEUROONE MEDICAL TECHNOLOGIES Corp on XNAS. In total, 51 filings are recorded, and across the recent filings sampled, sales total EUR 224225 between 2021-06-25 and 2026-04-01, with the most frequent transaction nature indicated as Tax withholding.